Literature DB >> 30651256

Greater illness severity characterises steroid diabetes following acute hospitalisation.

Nadine Abbas1, Mohammad Elhassan1, Philip Kelly1, Richard Yorke1, Omar G Mustafa1, Martin Brunel Whyte2.   

Abstract

Entities:  

Year:  2019        PMID: 30651256      PMCID: PMC6399644          DOI: 10.7861/clinmedicine.19-1-86

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

Review 1.  Stress hyperglycaemia.

Authors:  Kathleen M Dungan; Susan S Braithwaite; Jean-Charles Preiser
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

2.  Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality.

Authors:  Mark P Plummer; Rinaldo Bellomo; Caroline E Cousins; Christopher E Annink; Krishnaswamy Sundararajan; Benjamin A J Reddi; John P Raj; Marianne J Chapman; Michael Horowitz; Adam M Deane
Journal:  Intensive Care Med       Date:  2014-04-24       Impact factor: 17.440

3.  How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoid treatment?

Authors:  Vishal Narwani; Leyla Swafe; Chara Stavraka; Ketan Dhatariya
Journal:  Clin Med (Lond)       Date:  2014-06       Impact factor: 2.659

4.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

Authors:  Guillermo E Umpierrez; Scott D Isaacs; Niloofar Bazargan; Xiangdong You; Leonard M Thaler; Abbas E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.

Authors:  A Roberts; J James; K Dhatariya
Journal:  Diabet Med       Date:  2018-08       Impact factor: 4.359

  5 in total
  1 in total

Review 1.  Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?

Authors:  Martin Brunel Whyte; Prashanth R J Vas; Anne M Umpleby
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.